NCT00520377View on ClinicalTrials.gov

Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation

PHASE2UnknownINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

May 31, 2008

Conditions
Alveolar Ridge Augmentation
Interventions
DRUG

MD05

recombinant human GDF-5 coated onto beta-tricalcium phosphate

DEVICE

Beta-TCP and autologous bone

beta-tricalcium phosphate and autologous bone

Trial Locations (9)

12203

Charité Universitätsmedizin Berlin, Berlin

24105

Universitätsklinikum Schleswig Holstein, Kiel

40225

Universitätsklinik Düsseldorf, Düsseldorf

55131

Klinikum der Universität Mainz, Mainz

80336

Praxis Dr. Gath, München

81925

IPI München GmbH, München

82229

Praxis Dr. Schmidinger, Seefeld

91054

Universitätsklinik Erlangen, Erlangen

99089

Helios Klinik, Erfurt

Sponsors
All Listed Sponsors
collaborator

FGK Clinical Research GmbH

INDUSTRY

lead

Scil Technology GmbH

INDUSTRY